Literature Citations Close

Literature Citations for OriGene clone representing NM_000245


NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants, Shin, JS;Hong, SW;Moon, JH;Kim, JS;Jung, KA;Kim, SM;Lee, DH;Kim, I;Yoon, SJ;Lee, CG;Choi, EK;Lee, JY;Kim, KP;Hong, YS;Lee, JL;Kim, B;Choi, EK;Lee, JS;Jin, DH;Kim, TW;, Invest New Drugs. 2013 Oct 31

Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase Inhibitors , Christine M. Lovly, Johannes M. Heuckmann, Elisa de Stanchina, Heidi Chen, Roman K. Thomas, Chris Liang, and William Pao, Cancer Res., Jul 2011; 71: 4920 - 4931.

MET Receptor Sequence Variants R970C and T992I Lack Transforming Capacity, Jeffrey W. Tyner, Luke B. Fletcher, Ellen Q. Wang, Wayne F. Yang, Michael L. Rutenberg-Schoenberg, Carol Beadling, Motomi Mori, Michael C. Heinrich, Michael W. Deininger, Brian J. Druker, and Marc M. Loriaux, Cancer Res., Aug 2010; 70: 6233 - 6237

Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates, Cherlyn Ng, Rebecca A Jackson, Jan P Buschdorf, Qingxiang Sun, Graeme R Guy, J Sivaraman, The EMBO Journal 27, 804 - 816 (05 Mar 2008),